CLOs on the Move

Sorenson Capital

www.sorensoncap.com

 
Sorenson Capital is one of the leading providers in Business Services. It is based in Lehi, UT. To find more information about Sorenson Capital, please visit www.sorensoncap.com.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Novacomp

Novacomp is an IT service, consulting, and Business Process Outsourcing (BPO) company founded in 1997 and based in San José, Costa Rica. With over 600 employees and additional offices in Guatemala, Panama, Chile, Colombia, and the United States, Novacomp has more than 26 years of experience in delivering tailored technology solutions that enhance operational and strategic capabilities for clients across Latin America and beyond. The company offers a wide range of services, including software development, cloud and infrastructure services, robotic process automation, cybersecurity, and customer experience optimization. Novacomp focuses on creating complete digital ecosystems that integrate advanced technologies to drive innovation and operational excellence. It serves diverse industries and emphasizes personalized collaboration to meet the unique goals of each client. Recognized as a top B2B company in Costa Rica, Novacomp is committed to sustainable growth and positive community impact through its innovative solutions and expert talent.

summit search group

summit search group is a Calgary, AB-based company in the Business Services sector.

Credit Associates

Credit Associates is a Great Falls, MT-based company in the Business Services sector.

CFO Center

The worlds #1 provider of superstar part-time CFOs at a fraction of the cost of full-time resource. No recruitment fees | no tie-ins | immediate start.

Solos Health

Solos is a team of experienced IT veterans that formed a new technology company to help reduce the spread of COVID-19 leveraging both individualized machine learning and predictive analytics to continuously monitor individuals for the first indication...